UK charity launches new app to help men detect testicular cancer

NewsGuard 100/100 Score

A brand new “Check Yourself” free Testicular Cancer app has been launched by UK charity www.theoddballsfoundation.com. With over 16,000 new cases of testicular cancer diagnosed in the UK each year, early detection means 95% of males will make a complete recovery. Encouraging users to check themselves regularly will be a different celebrity each month with Alan Shearer featuring this December and international rugby referee Nigel Owens in January 2018.

The charity also helps to fund a male health program called “Offload”. Run by the Rugby Football League, it is a twelve week program designed to educate males on the importance of physical and mental health, with a week dedicated entirely to testicular cancer.

As the most common cancer in males aged 18 to 35, the app has already been welcomed by international rugby teams, premier league football clubs and cricket clubs.

Former Premier League footballer & Patron of the charity, Stephen Harper said:

Unless we get a reminder, most of us just don’t think about it.  Most of us have our phones in our hands, so there is no excuse not to download the app.  It’s very simple, with a monthly reminder so you can’t forget.  This could save your life.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer